Literature DB >> 21548648

A new and facile method to prepare uniform hollow MnO/functionalized mSiO₂ core/shell nanocomposites.

Yung-Kang Peng1, Chih-Wei Lai, Chien-Liang Liu, Hsieh-Chih Chen, Yi-Hsuan Hsiao, Wei-Liang Liu, Kuo-Chun Tang, Yun Chi, Jong-Kai Hsiao, Kun-Eng Lim, Hung-En Liao, Jing-Jong Shyue, Pi-Tai Chou.   

Abstract

Trifunctional uniform nanoparticles comprising a manganese nanocrystal core and a functionalized mesoporous silica shell (MnO@mSiO(2)(Ir)@PEG, where Ir is an emissive iridium complex and PEG is polyethylene glycol) have been strategically designed and synthesized. The T(1) signal can be optimized by forming hollow core (H-MnO@mSiO(2)(Ir)@PEG) via a novel and facile etching process, for which the mechanism has been discussed in detail. Systematic investigation on correlation for longitudinal relaxation (T(1)) versus core shapes and shell silica porosity of the nanocomposites (MnO, H-MnO, MnO@SiO(2), MnO@mSiO(2), H-MnO@mSiO(2)) has been carried out. The results show that the worm-like nanochannels in the mesoporous silica shell not only increase water permeability to the interior hollow manganese oxide core for T(1) signal but also enhance photodynamic therapy (PDT) efficacy by enabling the free diffusion of oxygen. Notably, the H-MnO@mSiO(2)(Ir)@PEG nanocomposite with promising r(1) relaxivity demonstrates its versatility, in which the magnetic core provides the capability for magnetic resonance imaging, while the simultaneous red phosphorescence and singlet oxygen generation from the Ir complex are capable of providing optical imaging and inducing apoptosis, respectively.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21548648     DOI: 10.1021/nn200928r

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  9 in total

1.  Manganese-based MRI contrast agents: past, present and future.

Authors:  Dipanjan Pan; Anne H Schmieder; Samuel A Wickline; Gregory M Lanza
Journal:  Tetrahedron       Date:  2011-11-04       Impact factor: 2.457

Review 2.  Fluorescent Mechanism in Zero-Dimensional Carbon Nanomaterials: A Review.

Authors:  Joselyn Elizabeth Abraham; Manoj Balachandran
Journal:  J Fluoresc       Date:  2022-03-18       Impact factor: 2.217

3.  Highly water-dispersible calcium lignosulfonate-capped MnO nanoparticles as a T 1 MRI contrast agent with exceptional colloidal stability, low toxicity and remarkable relaxivity.

Authors:  Mahdi Arian; Ali Zamanian; Salman Taheri
Journal:  RSC Adv       Date:  2019-12-06       Impact factor: 4.036

4.  Facile Synthesis of Multifunctional Magnetoplasmonic Au-MnO Hybrid Nanocomposites for Cancer Theranostics.

Authors:  Cong Tian; Zhe Tang; Yike Hou; Asim Mushtaq; Shafaq Naz; Zhangsen Yu; Jabeen Farheen; Muhammad Zubair Iqbal; Xiangdong Kong
Journal:  Nanomaterials (Basel)       Date:  2022-04-16       Impact factor: 5.719

Review 5.  Engineering of inorganic nanoparticles as magnetic resonance imaging contrast agents.

Authors:  Dalong Ni; Wenbo Bu; Emily B Ehlerding; Weibo Cai; Jianlin Shi
Journal:  Chem Soc Rev       Date:  2017-11-27       Impact factor: 54.564

6.  Development of manganese-based nanoparticles as contrast probes for magnetic resonance imaging.

Authors:  Zipeng Zhen; Jin Xie
Journal:  Theranostics       Date:  2012-01-01       Impact factor: 11.556

7.  Relaxivity and toxicological properties of manganese oxide nanoparticles for MRI applications.

Authors:  Benedict You Wei Hsu; Georgia Kirby; Aaron Tan; Alexander M Seifalian; Xu Li; John Wang
Journal:  RSC Adv       Date:  2016-05-10       Impact factor: 4.036

8.  Synthesis of Water-Based Dispersions of Polymer/TiO₂ Hybrid Nanospheres.

Authors:  Lu Jin; Hua Wu; Massimo Morbidelli
Journal:  Nanomaterials (Basel)       Date:  2015-08-28       Impact factor: 5.076

9.  MnO nanoparticles with potential application in magnetic resonance imaging and drug delivery for myocardial infarction.

Authors:  Yuanyuan Zheng; Hong Zhang; Yuping Hu; Lu Bai; Jingyi Xue
Journal:  Int J Nanomedicine       Date:  2018-10-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.